Immunomodulators as Therapeutic Agents in Mitigating the Progression of Parkinson’s Disease

Author： Grimmig Bethany   Morganti Josh   Nash Kevin   Bickford Paula C  

Publisher： MDPI

E-ISSN： 2076-3425|6|4|41-41

ISSN： 2076-3425

Source： Brain Sciences, Vol.6, Iss.4, 2016-09, pp. : 41-41

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitochondria: A Therapeutic Target for Parkinson’s Disease?

By Luo Yu   Hoffer Alan   Hoffer Barry   Qi Xin  

International Journal of Molecular Sciences, Vol. 16, Iss. 9, 2015-09 ,pp. : 20704-20730

MDPI

Access to resources Recommend Favorite

Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives

By Sarkar Sumit   Raymick James   Imam Syed  

International Journal of Molecular Sciences, Vol. 17, Iss. 6, 2016-06 ,pp. : 904-904

MDPI

Access to resources Recommend Favorite

Neurotransmitter CART as a New Therapeutic Candidate for Parkinson’s Disease

By Mao Peizhong   Meshul Charles K.   Thuillier Philippe   Reddy P. Hemachandra  

Pharmaceuticals, Vol. 6, Iss. 1, 2013-01 ,pp. : 108-123

MDPI

Access to resources Recommend Favorite

Therapeutic Potential of Induced Neural Stem Cells for Parkinson’s Disease

By Choi Dong-Hee   Kim Ji-Hye   Kim Sung Min   Kang Kyuree   Han Dong Wook   Lee Jongmin  

International Journal of Molecular Sciences, Vol. 18, Iss. 1, 2017-01 ,pp. : 224-224

MDPI

Access to resources Recommend Favorite

Protein Kinases and Parkinson’s Disease

By Mehdi Syed Jafar   Rosas-Hernandez Hector   Cuevas Elvis   Lantz Susan M.   Barger Steven W.   Sarkar Sumit   Paule Merle G.   Ali Syed F.   Imam Syed Z.  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-09 ,pp. : 1585-1585

MDPI

Access to resources Recommend Favorite